| CTRI Number |
CTRI/2013/08/003864 [Registered on: 02/08/2013] Trial Registered Retrospectively |
| Last Modified On: |
31/07/2013 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Surgical/Anesthesia |
| Study Design |
Randomized, Parallel Group, Active Controlled Trial |
|
Public Title of Study
|
comparison of two medicines used during anaesthesia for treatment of shivering |
|
Scientific Title of Study
|
A comparative study of Dexmedetomidine and tramadol for the treatment of post-spinal anaesthesia shivering |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Geeta Tayal |
| Designation |
Assistant Professor |
| Affiliation |
Department of Anaesthesiology, Dayanand Medical College and Hospital, Ludhiana, Punjab |
| Address |
Department of Anaesthesiology, Dayanand Medical College and Hospital, Ludhiana, Punjab
Ludhiana PUNJAB 141001 India |
| Phone |
919815528855 |
| Fax |
|
| Email |
geetatmittal@yahoo.co.in |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Geeta Tayal |
| Designation |
Assistant Professor |
| Affiliation |
|
| Address |
Department of Anaesthesiology, Dayanand Medical College and Hospital, Ludhiana, Punjab
Ludhiana PUNJAB 141001 India |
| Phone |
919815528855 |
| Fax |
|
| Email |
geetatmittal@yahoo.co.in |
|
Details of Contact Person Public Query
|
| Name |
Dr Geeta Tayal |
| Designation |
Assistant Professor |
| Affiliation |
|
| Address |
Department of Anaesthesiology, Dayanand Medical College and Hospital, Ludhiana, Punjab
Ludhiana PUNJAB 141001 India |
| Phone |
919815528855 |
| Fax |
|
| Email |
geetatmittal@yahoo.co.in |
|
|
Source of Monetary or Material Support
|
|
|
Primary Sponsor
|
| Name |
Dayanand Medical College Hospital Civil Lines Ludhiana |
| Address |
Civil Lines, Ludhiana, Punjab, India |
| Type of Sponsor |
Private medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Geeta Tayal |
Department of anaesthesia, Operation Theatre, Post-op recovery room, Dayanand Medical Hospital |
Dayanand Medical College and Hospital Civil Lines Ludhiana Ludhiana PUNJAB |
919815528855
geetatmittal@yahoo.co.in |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee, Dayanand Medical College & Hospital, Ludhiana |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
Patients undergoing spinal anesthesia and experiencing post spinal shivering, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
dexmedetomidine |
we wish to compare efficacy, potency and adverse effects of the Tramadol 0.5 mg/kg intravenous bolus with dexmedetomidine 0.5 µg/kg intravenous bolus in post-anaesthesia shivering. In case there was recurrence of shivering, patients were treated with additional dose of dexmedetomidine (0.5 μg/kg IV) or tramadol (0.5 mg/kg IV) in the respective groups |
| Intervention |
tramadol |
we wish to compare efficacy, potency and adverse effects of the Tramadol 0.5 mg/kg intravenous bolus with dexmedetomidine 0.5 µg/kg intravenous bolus in post-anaesthesia shivering. In case there was recurrence of shivering, patients were treated with additional dose of dexmedetomidine (0.5 μg/kg IV) or tramadol (0.5 mg/kg IV) in the respective groups |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
65.00 Year(s) |
| Gender |
Both |
| Details |
50 ASA grade-l & II patients of either gender aged 18 to 65 years scheduled for elective as well as emergency lower abdominal, lower limb, orthopaedic and plastic surgeries under spinal anaesthesia were included in the study. |
|
| ExclusionCriteria |
| Details |
Patients with known hypersensitivity to Dexmedetomidine or Tramadol, cardio-pulmonary, renal or hepatic disease, hyperthyroidism, psychiatric disorder, urinary tract infection, severe diabetes or autonomic neuropathies, known history of substance or alcohol abuse, patients receiving any pre-medication were not be included in the study |
|
|
Method of Generating Random Sequence
|
Random Number Table |
|
Method of Concealment
|
An Open list of random numbers |
|
Blinding/Masking
|
Participant Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Cessation of shivering |
time of cessation of shivering |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| level of sedation |
intra and post-operative |
|
|
Target Sample Size
|
Total Sample Size="50" Sample Size from India="50"
Final Enrollment numbers achieved (Total)= ""
Final Enrollment numbers achieved (India)="" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
01/01/2013 |
| Date of Study Completion (India) |
Date Missing |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Date Missing |
|
Estimated Duration of Trial
|
Years="0" Months="3" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Completed |
|
Publication Details
|
not published yet |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
|
Brief Summary
|
Post-spinal anaesthesia shivering is a frequent complication which can endanger the haemodynamic stability and recovery of patients. A number of drugs are being used out of which tramadol is an established agent. However, there is no ideal anti-shivering agent as the use of available drugs is associated with various adverse effects. The anti-shivering potential of dexmedetomidine is being explored recently in various trials which indicati it to be efficacious as well as free from any major adverse effect. We plan to do a randomised, controlled clinical study to compare the efficacy, potency, adverse and haemodunamic effects of tramadol and dexmedetomidine in 50 patients after IEC approval and written informed consent from each patient. |